Brief: RaQualia Pharma ends license agreement related to EP4 antagonist

RaQualia Pharma

29/11/2017 06:42

Nov 29 (Reuters) - RaQualia Pharma Inc  4579.T   
     
    * Says it ends license agreement with Maruishi 
Pharmaceutical Co 
Ltd regarding EP4 antagonist 
 
     
    Source text in Japanese:https://goo.gl/CxExhq 
    Further company coverage: 4579.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111; 
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))